SG3 Management, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$559,800
-47.7%
10,000
-51.7%
0.04%
-69.8%
Q2 2022$1,071,000
+96.5%
20,700
+176.0%
0.13%
+740.0%
Q1 2022$545,000
-89.8%
7,500
-81.2%
0.02%
-90.8%
Q3 2021$5,366,000
-77.0%
40,000
-72.2%
0.16%
-80.3%
Q2 2021$23,315,000
+1608.1%
144,000
+747.1%
0.83%
+2335.3%
Q1 2021$1,365,00017,0000.03%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders